Dies ist eine Übersichtsseite mit Metadaten zu dieser wissenschaftlichen Arbeit. Der vollständige Artikel ist beim Verlag verfügbar.
Recommendations to overcome barriers to the use of artificial intelligence-driven evidence in health technology assessment
35
Zitationen
20
Autoren
2023
Jahr
Abstract
In the field of HTA, the great potential of AI to support evidence generation and evaluation has not yet been sufficiently explored and realized. Raising awareness of the intended and unintended consequences of AI-based methods and encouraging political commitment from policymakers is necessary to upgrade the regulatory and infrastructural environment and knowledge base required to integrate AI into HTA-based decision-making processes better.
Ähnliche Arbeiten
Meta-analysis in clinical trials
1986 · 38.733 Zit.
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement
2009 · 37.535 Zit.
PRISMA Extension for Scoping Reviews (PRISMA-ScR): Checklist and Explanation
2018 · 37.057 Zit.
The Cochrane Collaboration's tool for assessing risk of bias in randomised trials
2011 · 33.449 Zit.
RoB 2: a revised tool for assessing risk of bias in randomised trials
2019 · 28.303 Zit.
Autoren
Institutionen
- University of Pecs(HU)
- Syreon Research Institute (Hungary)(HU)
- Medical University of Sofia(BG)
- University of Pannonia(HU)
- Cairo University(EG)
- National Institute for Health and Care Excellence(GB)
- Utrecht University(NL)
- Zorginstituut Nederland(NL)
- Bioef - Fundación Vasca de Innovación e Investigación Sanitarias(ES)
- University of Ljubljana(SI)
- Universitatea de Medicină, Farmacie, Științe și Tehnologie „George Emil Palade” din Târgu Mureș(RO)
- European Organisation for Research and Treatment of Cancer(BE)
- Ministry of Health(UA)
- National Center of Infectious and Parasitic Diseases(BG)
- Comenius University Bratislava(SK)
- Ministry of Health(SI)
- Semmelweis University(HU)